212 related articles for article (PubMed ID: 17108142)
1. An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
Acconcia F; Manavathi B; Mascarenhas J; Talukder AH; Mills G; Kumar R
Cancer Res; 2006 Nov; 66(22):11030-8. PubMed ID: 17108142
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
3. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
[TBL] [Abstract][Full Text] [Related]
4. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
5. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
Hua KT; Way TD; Lin JK
Mol Carcinog; 2006 Aug; 45(8):551-60. PubMed ID: 16637063
[TBL] [Abstract][Full Text] [Related]
6. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Weitsman GE; Weebadda W; Ung K; Murphy LC
Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
[TBL] [Abstract][Full Text] [Related]
8. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling.
Qian Y; Zhong X; Flynn DC; Zheng JZ; Qiao M; Wu C; Dedhar S; Shi X; Jiang BH
Oncogene; 2005 Apr; 24(19):3154-65. PubMed ID: 15735674
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
[TBL] [Abstract][Full Text] [Related]
10. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.
McDonald PC; Oloumi A; Mills J; Dobreva I; Maidan M; Gray V; Wederell ED; Bally MB; Foster LJ; Dedhar S
Cancer Res; 2008 Mar; 68(6):1618-24. PubMed ID: 18339839
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B.
Agouni A; Sourbier C; Danilin S; Rothhut S; Lindner V; Jacqmin D; Helwig JJ; Lang H; Massfelder T
Carcinogenesis; 2007 Sep; 28(9):1893-901. PubMed ID: 17468516
[TBL] [Abstract][Full Text] [Related]
13. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
14. P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.
Rayala SK; Talukder AH; Balasenthil S; Tharakan R; Barnes CJ; Wang RA; Aldaz CM; Khan S; Kumar R
Cancer Res; 2006 Feb; 66(3):1694-701. PubMed ID: 16452229
[TBL] [Abstract][Full Text] [Related]
15. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
St-Laurent V; Sanchez M; Charbonneau C; Tremblay A
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
17. Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Oncogene; 2006 Jun; 25(23):3237-46. PubMed ID: 16407822
[TBL] [Abstract][Full Text] [Related]
18. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway.
Pasquet JM; Noury M; Nurden AT
Thromb Haemost; 2002 Jul; 88(1):115-22. PubMed ID: 12152651
[TBL] [Abstract][Full Text] [Related]
20. The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer.
Boulay A; Breuleux M; Stephan C; Fux C; Brisken C; Fiche M; Wartmann M; Stumm M; Lane HA; Hynes NE
Cancer Res; 2008 May; 68(10):3743-51. PubMed ID: 18483257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
